Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

Not Applicable

Not yet recruiting

• Conditions: Anxiety Disorders; Mood Disorders
• Interventions: Other: Standard videoconferencing; Other: Teleo

• Registration Number: NCT06364137
• Lead Sponsor: Stanford University

Brief Summary

The research study will examine engagement in telehealth for children undergoing psychotherapy. Specifically, the pilot trial will examine examine patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.

Detailed Description

The research study will examine engagement in telehealth for children undergoing psychotherapy. The study in Phase I entails a pilot randomized trial with a goal to enroll 42 families, examining patient engagement in Teleo, a virtual therapy platform specifically designed for psychotherapy with youth, as compared to standard video conferencing.

Engagement will be assessed using well-established measures - PRIME-O (modified) video coding, MTT-Y/MTTCG and attendance data (sessions 1-4). Clinicians in the study will deliver therapy to clients for 4 sessions, providing opportunity to measure temporal sustainment of any engagement differences.

Study Timeline

• Study First Submitted: 2024-04-08
• Study First Submitted QC: 2024-04-08
• Study First Posted: 2024-04-15
• Status Verified: 2024-11
• Last Update Submitted: 2024-11-29
• Last Update Posted: 2024-12-02
• Study Start: 2025-01-01
• Primary Completion: 2025-06-30
• Study Completion: 2025-06-30

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

• Patient ages 5-14
• Receiving psychotherapy with a licensed professional on the Teleo platform
• Likely have at least 12 sessions remaining.
• RCADS score > 65

Exclusion Criteria

• Not under treatment with provider using Teleo platform

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Standard videoconferencing	Standard videoconferencing	Participants in this group will under therapy for 4 sessions using standard video platforms (e.g. zoom or other publicly available product), sessions will be recorded and questionnaires and clinical data will be measured.
Teleo	Teleo	Participants in this group will under therapy for 4 sessions using the Teleo virtual therapy video platform, sessions will be recorded and questionnaires and clinical data will be measured.

Primary Outcome Measures

Name	Time	Method
PRIME-O Video Coding Score	Weeks 1, 2, 3, 4	Assess therapeutic engagement using modified PRIME-O total score, group scores, and individual item sub-scores. Scores range from 0-40, higher scores indicate 'better' outcome.

Secondary Outcome Measures

Name	Time	Method
My Thoughts about Therapy - Caregiver (MTT-CG) engagement questionnaire scores	Post-intervention (at one month)	Caregivers will complete modified MTT-CG questionnaire to measure engagement across dimensions of the REACH client engagement framework - Relationship, Expectancy, Attendance, Clarity, and Homework. Scores range from 0-105, higher scores indicate 'better' outcome.
My Thoughts about Therapy - Youth (MTT-Y) engagement questionnaire scores	Post-intervention (at one month)	Youth will complete questionnaires to measure self-reported engagement across dimensions of the REACH client engagement framework - Relationship, Expectancy, Attendance, Clarity, and Homework. Scores range from 0-105, higher scores indicate 'better' outcome.
Attendance during Psychotherapy Sessions	One month	Instances and frequency of appointment cancellations, appointment no-shows, and/or discontinuation of therapy will be recorded and analyzed.

Trial Locations

Locations (1)

Stanford University; 🇺🇸 Stanford, California, United States